5 results
To evaluate whether dGEMRIC is suitable as outcome measure to detect changes over time, and also between intervention groups in patients with OA of the knee.
To assess whether there is (cost) effectiveness over a period of 1 year of additive intra-articular injections with a high molecular HA derivate in patients with OA of the knee.
Primary objective The primary objective of the study is the evaluation of the therapeutic benefit of three repeated dose intratympanic AM 101 injections in comparison to placebo in the treatment of persistent acute inner ear tinnitus following acute…
Phase 1:The primary objective of this trial is to investigate whether oral esketamine is non-inferior to ECT after eight weeks of individually optimized treatment, in participants with NTRD.Phase 2:To compare the efficacy of maintenance oral…
To investigate whether oral esketamine is non-inferior to ECT in achieving treatment response on depression severity in NTRD.